1,3-Diisopropoxy-1,1,3,3-tetramethyldisiloxane, 97%, 500mg

(-)-N,N,N',N'-Tetramethyl-D-tartardiamide>98.0%(GC)(N)25g

CEFDITOREN PIVOXIL, 98%, 1g

1-(difluoromethyl)-1H-pyrazole-4-carboxylic acid, 10g

(S)-N-((R)-1-cyclopropyl-2,2,2-trifluoroethyl)-2-methylpropane-2-sulfinamide, 98%, 1g

METHYL 3-AMINO-4-FLUORO-2-METHYLBENZOATE, 95%, 1g

(3R,4S)-3-FLUORO-4-METHOXYPIPERIDINE HYDROCHLORIDE, 95%, 1g

Ultrasonic device series D, 11.5 l, D 130 1 piece

Lithium Bis(trifluoromethanesulfonyl)imide>98.0%(T)250g

(R)-1-(4-(Trifluoromethoxy)phenyl)ethanamine, 95.0%, 250mg

TASELISIB, 95%, 50mg

4-ethyl-5-[(4-methoxyphenoxy)methyl]-4H-1,2,4-triazole-3-thiol, 95.0%, 1g

2-Phenyl-1H-imidazole-4-carbaldehyde, 95.0%, 1g